Aperio's Stacey King and Mike Ferree Talk Risk Based Quality Management at SCDM 2021

SEPTEMBER 15, 2021

Aperio’s Stacey King will facilitate an On Demand session for Society for Clinical Data Management 2021 titled “Risk Based Quality Management – Every Piece of the Puzzle Matters.”

During the session, Stacey and her esteemed panelists will discuss the different components of RBQM; the roles and responsibilities of RBQM and Centralized Monitoring Analytics; why it’s critical to implement a QbD approach to study design; and how the field of Clinical Data Management is evolving.

Stacey will be joined by a panel of industry experts, including Aperio’s Micheal Ferree, Medidata’s Brian Barnes, Pfizer’s Crupa K., and CMED’s Rachel Oakley.

The On Demand session is available on the Society for Clinical Data Management (SCDM) 2021 website Sept. 19th -29th. You can access the session here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com